ENTITY
Wuxi Biologics

Wuxi Biologics (2269 HK)

707
Analysis
Health Care • China
Wuxi Biologics is a global Contract Research, Development, and Manufacturing Organization (CRDMO) offering end-to-end solutions for biologics discovery, development, and manufacturing, including complex modalities like monoclonal antibodies and antibody-drug conjugates. The company provides comprehensive services from concept to commercialization, including vaccine CRDMO services. It was founded in 2010 and is headquartered in Wuxi, China.
more
•08 Feb 2026 10:10

HK Short Interest Weekly: Alibaba, AIA, Sinopec, CATL

We analyzed the latest HK SFC report for aggregate short position as of Jan 30th and highlight short interest changes in Alibaba, AIA, Sinopec, CATL.

Logo
307 Views
Share
•03 Feb 2026 05:55

Aequitas: Eastroc Beverage A/H Trading - Weak Retail, Strong Insti Demand

Eastroc Beverage Group (605499 CH) (EB), a China-based functional beverage company, raised around US$1.5bn in its H-share listing. In this note, we...

Logo
296 Views
Share
•30 Jan 2026 11:33

Hong Kong Buybacks Weekly (Jan 30th): Sunny Optical, Geely Automobile, Country Garden Services

We analyzed the Hong Kong buyback data in the past week and highlight the top 3 companies that repurchased the most shares were Sunny Optical,...

Logo
204 Views
Share
•26 Jan 2026 15:21

Eastroc Beverage A/H Listing - Good Quality but Tight Pricing

Eastroc Beverage Group (605499 CH) (EB), a China-based functional beverage company, aims to raise around US$1.3bn in its H-share listing. In this...

Logo
307 Views
Share
bullish•CK Hutchison
•25 Jan 2026 06:30

Last Week In Event SPACE: Toyota Industries, Skyworth Group, CK Hutchison, Dongfeng Motor

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
289 Views
Share
x